Comparative study of Infliximab monotherapy vs combined therapy with azathiopurine for inducing and maintaining clinical remission in steroid-dependent or -resistant ulcerative colitis
Not Applicable
- Conditions
- ulcerative colitis
- Registration Number
- JPRN-UMIN000006141
- Lead Sponsor
- Department of Gastroenterology and Hepatology, Kyoto University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who are required total colectomy or subtotal colectomy 2) Patients with severe active ulcerative colitis (CAI; more than 12) 3) Patients with malignancy 4) Patients with intestinal stenosis to cause intestinal obstruction 5) Patients with serious extraintestinal complication 6) Patients who are pregnant or desire pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method